Search
for
Sort by
Research 541–570 of 1000+
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Alopecia Areata and Alopecia Areata Incognita
- Fatal Toxic Epidermal Necrolysis Associated With Cetuximab in a Patient With Colon Cancer
- Clinical and biological impact of the exposome on the skin
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IgG and IgA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- ASSESSMENT OF SERUM LEVELS OF ANTIGLIADIN ANTIBODIES (IGG AND IGA) IN PATIENTS WITH ALOPECIA AREATA AND THEIR RELATION TO SEVERITY OF THE DISEASE
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Immunomodulators in the treatment of cutaneous lymphoma
- Evidence for the off-label use of tofacitinib in alopecia areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Hypopigmented Mycosis Fungoides Treated with 308 nm Excimer Laser
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Exploring the association between alopecia areata and thyroid dysfunction: A review
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Therapeutic potential and pharmacological insights of total glucosides of paeony in dermatologic diseases: a comprehensive review
- A Comprehensive Systematic Review of the Association Between Vitamin D Deficiency and Alopecia Areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Epidemiology and burden of alopecia areata: a systematic review
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Teriflunomide (Aubagio®) for the treatment of multiple sclerosis
- COVID-19 infection leading to acute pustular dermatoses
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- Drug eruptions in dermatology
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Oxidative stress and alopecia areata